Replies to post #676605 on NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

Captain,

I was thinking that the reason rgbm did so well in the crossover group, was the immune system had more time to recover before DCVax treatments started.

.

Remember that the recurrent tumor has often undergone a mutation and mutated to the Mesenchymal.type.
And as we all know, Mesenchymal is the worst type but delivers the best results with DCvax.